<code id='871B3CBC1C'></code><style id='871B3CBC1C'></style>
    • <acronym id='871B3CBC1C'></acronym>
      <center id='871B3CBC1C'><center id='871B3CBC1C'><tfoot id='871B3CBC1C'></tfoot></center><abbr id='871B3CBC1C'><dir id='871B3CBC1C'><tfoot id='871B3CBC1C'></tfoot><noframes id='871B3CBC1C'>

    • <optgroup id='871B3CBC1C'><strike id='871B3CBC1C'><sup id='871B3CBC1C'></sup></strike><code id='871B3CBC1C'></code></optgroup>
        1. <b id='871B3CBC1C'><label id='871B3CBC1C'><select id='871B3CBC1C'><dt id='871B3CBC1C'><span id='871B3CBC1C'></span></dt></select></label></b><u id='871B3CBC1C'></u>
          <i id='871B3CBC1C'><strike id='871B3CBC1C'><tt id='871B3CBC1C'><pre id='871B3CBC1C'></pre></tt></strike></i>

          hotspot

          hotspot

          author:entertainment    Page View:58
          This image provided by Novo Nordisk in January 2023, shows packaging for the company's Wegovy drug.
          Novo Nordisk via AP

          PHILADELPHIA — Novo Nordisk’s obesity drug Wegovy notably cut the risk of heart attacks in a landmark cardiovascular trial that affirms the treatment offers health benefits beyond weight loss.

          The company in August had announced that in this trial, called Select, Wegovy reduced the overall rate of major heart problems — heart attacks, stroke, or cardiovascular-related death — by 20%. That finding, which was the primary outcome the trial set out to study, was stronger than many were expecting and led Novo’s stock to surge.

          advertisement

          But details of the study, including risk reductions for each specific heart complication, were not released until Saturday, when they were presented here — before a standing-room only crowd — as the first major session of the American Heart Association conference. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          The 10 drugs up first for Medicare price negotiation
          The 10 drugs up first for Medicare price negotiation

          PresidentBiden'sWhiteHouseannouncedthefirst10medicinesthatwillbeupfirstinitsnewdrugpricenegotiationp

          read more
          In Memoriam: Notable people who died in 2023
          In Memoriam: Notable people who died in 2023

          1:29AlanArkinattendsthe26thAnnualScreenActorsGuildAwardsatTheShrineAuditoriumonJan.19,2020inLosAngel

          read more

          ALS advocates say criticism of new drugs misses bigger picture

          BrianWallachandSandraAbrevayaofIAmALSspokewithreporterDamianGardeattheSTATFutureSummit.STATAdiagnosi